MétaCan
Menu
Back to cohort

PB2497: HEMATOLOGIC TOXICITIES WITH IMMUNOTHERAPY IN CANCER PATIENTS AT THE ALLAN BLAIR CANCER CENTRE: RETROSPECTIVE DATA COLLECTION STUDY

2023· article· en· W4385704562 on OpenAlexaffabout
Amani Khan, Ibraheem Othman, Shubrandu Sanjoy, Sandy Kassir, Osama Souied

Bibliographic record

VenueHemaSphere · 2023
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsSaskatchewan Health AuthoritySaskatchewan HealthUniversity of Saskatchewan
Fundersnot available
KeywordsMedicineCancerImmunotherapyInternal medicineOncologyContext (archaeology)Incidence (geometry)NeutropeniaChemotherapy

Abstract

fetched live from OpenAlex

Topic: 25. Gene therapy, cellular immunotherapy and vaccination - Clinical Background: Immunotherapy, particularly checkpoint inhibitors, has demonstrated significant clinical benefits in the treatment of various malignancies. However, these novel therapies can also lead to serious and potentially life-threatening toxicities. This necessitates further investigation into the incidence and nature of these toxicities in clinical practice. Aims: The aim of this retrospective chart review study was to identify the proportion and context of patients treated at the Allan Blair Cancer Centre who experienced immunotherapy-related toxicities. We focused specifically on hematologic toxicities in order to provide clinicians with a better understanding of the risks associated with this drug class. Methods: We reviewed a total of 486 patient charts from the Saskatchewan Cancer Agency, pertaining to patients who received immunotherapy for any indication between 2013, when immunotherapy began being administered within the system, and May 30th, 2020. Patients with various tumour types who received anti-programmed cell death 1 (PD-1) and/or anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), with or without chemotherapy, and experienced anemia, neutropenia, or thrombocytopenia within a time frame of therapy were included. Breast, gastrointestinal, sarcoma, and neuroendocrine tumours were excluded. We collected data on the incidence of hematologic toxicities and the management of these toxicities in clinical practice, using a data collection tool in REDCap. Results: Among the charts identified, 430 patients met the inclusion criteria. The mean age was 70.3±11.2 years, and 50.8% were female. The overall rate of immunotherapy-related reactions was 47.3%, whereas anemia, thrombocytopenia and neutropenia were 93.5%, 21.3% and 11.3%, respectively. Patients with combination immunotherapy and chemotherapy had a lower incidence of anemia (4.1% versus 15.3%, P<0.001), thrombocytopenia (6.9% versus 28.6%, P<0.001) and neutropenia (5.9% versus 65.4%, P<0.001). Summary/Conclusion: The incidence of immunotherapy-related anemia was the most significant finding in our data. Most of the reactions were less common in the combination therapy cohort. The outcome of this research may assist clinicians in identifying the risks burdening patients undergoing cancer treatment and establishing best management practices to reduce patient morbidity and mortality. Keywords: Toxicity, Cancer immunotherapy

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.077
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.312
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueHemaSphereSame topicCancer Immunotherapy and BiomarkersFrench-language works237,207